Omeros announces update on statistical analysis of narsoplimab primary endpoint
Omeros (OMER) announced statistical sensitivity analysis results related to the primary endpoint analysis for narsoplimab, Omeros’ monoclonal ...
Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint
Omeros Corporation (Nasdaq: OMER) today announced statistical sensitivity analysis results related to the primary endpoint ...
British Swimming20d
World Class Pathway
In recognising this UK Sport’s approach to funding reflects that journey and works on the basis of an athlete pathway with three clear and distinct levels that make up the World Class Pathway. The two ...